GHRH analog raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
This page was last updated on 2026-06-10 and is reviewed periodically as new material appears.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
The peptide backbone corresponds to GRF(1-29), the first 29 residues of native growth hormone-releasing hormone, which retains most of the receptor-activating activity of the full-length molecule. Four substitutions distinguish the analog from the natural sequence: D-alanine at position 2, glutamine at position 8, alanine at position 15, and leucine at position 27. These changes slow cleavage by dipeptidyl peptidase IV, the enzyme that degrades native hormone in plasma within minutes. The outcome is improved enzymatic stability combined with a still brief residence time when no additional modification is present.
Naming in this area is inconsistent, and readers should treat product labels with care. In much of the literature and in vendor catalogs, the unqualified term refers to the albumin-binding version, while the version lacking the DAC group appears as modified GRF(1-29), mod GRF(1-29), or the same name with a without-DAC qualifier. Because one abbreviation has been applied to both materials, the only reliable way to identify a sample is to check the stated sequence and the presence of the linker.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide | GHRH analog, not a steroid |
| Backbone length | 29 amino acids | Based on GRF(1-29) |
| Substitutions | Four positions | D-Ala2, Gln8, Ala15, Leu27 |
| Appearance | White to off-white powder | Typical lyophilized research material |
| Common synonyms | Modified GRF(1-29) | Usage varies between sources |
Downstream of growth hormone, the liver and other tissues increase production of insulin-like growth factor 1, a mediator of many growth-promoting effects. Studies have documented elevated levels of both hormones after dosing, and the rise from the long-acting form persists longer than that produced by shorter-acting analogues. What remains unclear is whether sustained elevation of these markers translates into meaningful clinical benefit, and whether prolonged exposure carries risks that short trials could not detect.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
Batch-to-batch consistency depends on solid-phase peptide synthesis and subsequent purification. Coupling efficiency, resin choice, and cleavage conditions all affect the final profile. Counter-ion content and moisture can shift the apparent mass of a batch. Documentation typically includes a certificate of analysis with chromatograms and spectra. Independent verification by a second laboratory is sometimes requested. Whether a given certificate reflects the actual vial contents depends on chain of custody. Analytical methods themselves carry uncertainty that should be stated alongside results.
Lyophilized material is typically stored at minus twenty degrees Celsius or lower. Keeping the vial dry and protected from light preserves peptide integrity. Repeated freeze-thaw cycles can cause aggregation or loss of activity. Once dissolved, solutions are generally kept at two to eight degrees Celsius. Stability data for reconstituted solutions vary, and long-term behavior is not fully established. Working aliquots reduce the number of times a stock container is opened.
18-Methoxycoronaridine (18-MC; developmental code name MM-110), also known as zolunicant (INNTooltip International Nonproprietary Name), is a derivative of ibogaine invented in 1996 by the research team around the pharmacologist Stanley D. Glick from the Albany Medical College and the chemists Upul K. Bandarage and Martin E. Kuehne from the University of Vermont. 18-MC was originally developed by Savant HWP and later acquired by MindMed in 2019 for development as a treatment for opioid use disorder. A Phase 1 trial in healthy volunteers was completed in 2022 with favorable safety and tolerability. Due to strategic reprioritization, MindMed discontinued active development of MM-110 in 2023 and has been seeking non-dilutive funding or partners to potentially restart the program; as of 2025 the program remains shelved. A separate Phase 2 trial in Brazil for cutaneous leishmaniasis (initiated 2017) has unknown status with no published results.
In medicine, health, or physical fitness, weight loss is a reduction of the total body mass, by a mean loss of fluid, body fat (adipose tissue), or lean mass (namely bone mineral deposits, muscle, tendon, and other connective tissue). Weight loss can either occur unintentionally because of malnourishment or an underlying disease, or from a conscious effort to improve an actual or perceived overweight or obese state. "Unexplained" weight loss that is not caused by reduction in calorific intake or increase in exercise is called cachexia and may be a symptom of a serious medical condition.
== Signs and symptoms == With single or prolonged exposure by inhalation the lungs may become sensitized to beryllium. Berylliosis has a slow onset and progression. Some people who are sensitized to beryllium may not have symptoms. Continued exposure causes the development of small inflammatory nodules, called granulomas. Of note, the authors of a 2006 study suggested that beryllium inhalation was not the only form of exposure and perhaps skin exposure was also a cause, as they found that a reduction in beryllium inhalation did not result in a reduction in chronic beryllium disease or beryllium sensitization. Granuloma formation is seen in other diseases such as tuberculosis and sarcoidosis. Sarcoidosis, like berylliosis, also produces granulomas without a necrotic core, and so distinction between the two processes can be difficult. Ultimately, this process leads to restrictive lung disease (a decrease in diffusion capacity). The earliest symptoms are typically cough and shortness of breath. Other symptoms include chest pain, joint aches, weight loss, and fever. Rarely, one can get granulomas in other organs including the liver. The onset of symptoms can range from weeks up to tens of years from the initial exposure. In some individuals, a single exposure to beryllium can cause berylliosis.
== Economy == Major employers in Lebanon include Lebanon Community School Corporation; the U.S. headquarters of German power tools company Festool and of Canadian specialty foods manufacturer Skjodt-Barrett; manufacturing plants for Hendrickson International, DS Smith, Kuraray, Kauffman Engineering, Maplehurst Bakeries, and D-A Lubricant Company; distribution centers for CNH Parts & Services, Subaru of America, Continental Tire the Americas, and Hachette Book Group USA; and health care and medical facilities operated by Witham Health Services. Lebanon is also the site of LEAP Research and Innovation District, an economic development initiative involving over 9,000 acres of land that will be allocated for technological and manufacturing projects. The area will be able to employ around 50,000 workers upon completion. Among the investments at LEAP is a $9 billion facility for Eli Lilly and Company that will produce active pharmaceutical ingredients for the antidiabetic medication Tirzepatide starting in late 2026.
Sources: en.wikipedia.org
The modifications covered in this diagram have to do with stereochemistry and the assignment of unique Cahn-Ingold-Prelog R/S assignments to complex analogues of fentanyl. The stereochemistry of fentanyl analogues can seem at first counter-intuitive, because of the complex and unique nature of the reasoning organic chemists must develop to internalize complex three dimensional geometries such as those needed to comprehend stereochemistry. Thankfully these images follow a simple procedure for organizing a potential analogue of fentanyl into the total number of unique stereoisomers, the number of true stereocenters on the molecule, and the number of Cahn-Ingold-Prelog R/S assignments that are appropriate for that analogue. The procedure used in the analysis of stereochemistry in these series of images is the following:
=== Biological === An MRI study conducted on Price provides a plausible argument as to the neurological foundation of her superior memory. Both the temporal lobe and the caudate nucleus were found to be enlarged. Parker and colleagues speculated that a defective frontostriatal circuit could be responsible for the observed executive function deficits in hyperthymesia. This circuit plays a crucial role in some neurodevelopmental disorders including obsessive–compulsive disorder and Alzheimer's. Given the parallels in some aspects of behavior, Price's hyperthymestic abilities possibly stem from atypical neurodevelopment. Scientists now need to ascertain if and how these brain areas are connected to establish a coherent neurological model for superior autobiographical memory. For autobiographical memory, the hippocampus, located in the medial temporal lobe, is involved in the encoding of declarative memory (memory for facts and events), while the temporal cortex is involved in the storage of such memory. The caudate nucleus is primarily associated with procedural memory, in particular habit formation, and is, therefore, intrinsically linked to obsessive-compulsive disorder. A 2018 clinical trial published that there were higher levels of activation in the medial prefrontal cortex and temporoparietal junction along with heightened connection between the prefrontal cortex and the hippocampus in hyperthymesiacs, suggesting that these regions may play a role in the enablement of the condition.
1993/1789) Criminal Justice Act 1988 (Designated Countries and Territories) (Amendment) Order 1993 (S.I. 1993/1790) Criminal Justice (International Co-operation) Act 1990 (Enforcement of Overseas Forfeiture Orders) (Amendment) Order 1993 (S.I. 1993/1791) Drug Trafficking Offences Act 1986 (Designated Countries and Territories) (Amendment) Order 1993 (S.I. 1993/1792) Haiti (United Nations Sanctions) (Channel Islands) Order 1993 (S.I. 1993/1793) Haiti (United Nations Sanctions)(Isle of Man) Order 1993 (S.I. 1993/1794) Hong Kong (British Nationality) (Amendment) Order 1993 (S.I. 1993/1795) Immigration (Guernsey) Order 1993 (S.I. 1993/1796) Immigration (Jersey) Order 1993 (S.I. 1993/1797) Iraq (United Nations) (Sequestration of Assets) (Guernsey) Order 1993 (S.I. 1993/1798) Iraq (United Nations) (Sequestration of Assets) (Jersey) Order 1993 (S.I. 1993/1799)
In horticulture, lime sulfur (lime sulphur in British English; see American and British English spelling differences) is mainly a mixture of calcium polysulfides and thiosulfate (plus other reaction by-products such as sulfite and sulfate), formed by reacting calcium hydroxide with elemental sulfur, and is used in pest control. It can be prepared by boiling a suspension of poorly soluble calcium hydroxide (lime) and solid sulfur in water, together with a small amount of surfactant to facilitate the dispersion of these solids. After elimination of residual solids (flocculation, decantation, and filtration), it is normally used as an aqueous solution, which is reddish-yellow in color and has a distinctive offensive odor of hydrogen sulfide (H2S, rotten eggs).
=== Introns can be mobile genetic elements === Some self-splicing introns can spread through a population of organisms by "homing", inserting copies of themselves into genes at sites that previously lacked an intron. Because they are self-splicing (that is, they remove themselves at the RNA level from genes into which they have inserted), these sequences represent transposons that are genetically silent, i.e. they do not interfere with the expression of the gene into which they become inserted. These introns can be regarded as examples of selfish DNA. Some mobile introns encode homing endonucleases, enzymes that initiate the homing process by specifically cleaving double-stranded DNA at or near the intron-insertion site of alleles lacking an intron. Mobile introns are frequently members of either the group I or group II families of self-splicing introns.
Sources: en.wikipedia.org
The name was not commonly used for the whole mountain range until the late 19th century. A competing and often more popular name was the "Allegheny Mountains", "Alleghenies", and even "Alleghania". In the early 19th century, Washington Irving proposed renaming the United States either Appalachia or Alleghania. In U.S. dialects in most regions of the Appalachians, the word is pronounced , with the third syllable sounding like "latch". In some northern parts of the mountain range, particularly Pennsylvania, it is pronounced or ; the third syllable is like "lay", and the fourth "chins" or "shins". There is often great debate between the residents of the regions regarding the correct pronunciation. Elsewhere, a commonly accepted pronunciation for the adjective Appalachian is , with the last two syllables "-ian" pronounced as in the word "Romanian".
== Richest royals == The Crown Property Bureau presides over the wealth of Thailand's king and royal family, judged to be the world's richest. Its holdings include over 7,588 rai (1,214.1 ha; 3,000 acres) of land in central Bangkok and shares in Siam Cement and Siam Commercial Bank. The king also owns the 545-carat Golden Jubilee Diamond, the largest cut and faceted diamond in the world.
==== United Kingdom ==== From October 2011 as part of the Modernising Scientific Careers scheme, the route to accreditation as a medical physicist in England and Wales is provided by the Scientist Training Programme (STP). This scheme is a three-year graduate program provided by the National School of Healthcare Science. Entrants are required to have an undergraduate degree (first or upper second class honours) in an appropriate physical science prior to this three-year graduate program. The STP involves a part-time MSc in Medical Physics (provided by either King's College London, University of Liverpool or Newcastle University) in addition to practical training within the National Health Service. Assessment is provided by the completion of competencies and by a final assessment similar to the OSCE undertaken by other clinical staff. Completion of the STP leads to accreditation by the Institute of Physics and Engineering in Medicine (IPEM) and registration as a Clinical Scientist with the Health and Care Professions Council (HCPC). Prior to 2011 the training route in the United Kingdom was administered in two parts, and this scheme is still used in Scotland (known as the Scottish Medical Physics and Clinical Engineering Training Scheme (SMPCETS)). Part I involves limited clinical experience and a full-time MSc in medical physics. Part II involves exclusively clinical experience in which the candidate would produce a portfolio of experience and submit to the Academy for Healthcare Science which (in addition to a viva) would lead to professional accreditation by IPEM.
With the development of these three techniques, the field of structural biology expanded and also became a branch of molecular biology, biochemistry, and biophysics concerned with the molecular structure of biological macromolecules (especially proteins, made up of amino acids, RNA or DNA, made up of nucleotides, and membranes, made up of lipids), how they acquire the structures they have, and how alterations in their structures affect their function. This subject is of great interest to biologists because macromolecules carry out most of the functions of cells, and it is only by coiling into specific three-dimensional shapes that they are able to perform these functions. This architecture, the "tertiary structure" of molecules, depends in a complicated way on each molecule's basic composition, or "primary structure." At lower resolutions, tools such as FIB-SEM tomography have allowed for greater understanding of cells and their organelles in 3-dimensions, and how each hierarchical level of various extracellular matrices contributes to function (for example in bone). Computational methods can also predict molecular structures with high accuracy, complementing the experimental study of biological structures. Computational techniques such as molecular dynamics simulations can be used in conjunction with empirical structure determination strategies to extend and study protein structure, conformation and function.
=== Effects === Behavioral effects can vary by dosage. Low doses produce numbness in the extremities and intoxication, characterized by staggering, unsteady gait, slurred speech, bloodshot eyes, and loss of balance. Moderate doses (5–10 mg intranasal, or 0.01–0.02 mg/kg intramuscular or intravenous) will produce analgesia and anesthesia. High doses may lead to convulsions. The drug is often illegally produced under poorly controlled conditions; this means that users may be unaware of the actual dose they are taking. Psychological effects include severe changes in body image, loss of ego boundaries, paranoia, and depersonalization. Psychosis, agitation and dysphoria, hallucinations, blurred vision, euphoria, and suicidal impulses are also reported, as well as occasional aggressive behavior. PCP may induce feelings of strength, power, and invulnerability as well as a numbing effect on the mind. Studies by the Drug Abuse Warning Network in the 1970s show that media reports of PCP-induced violence are greatly exaggerated and that incidents of violence are unusual and often limited to individuals with reputations for aggression regardless of drug use. Although uncommon, events of PCP-intoxicated individuals acting in an unpredictable fashion, possibly driven by their delusions or hallucinations, have been publicized. Other commonly cited types of incidents include inflicting property damage and self-mutilation of various types, such as pulling out one's teeth.
Sources: en.wikipedia.org
No. It is a laboratory-made analog of growth hormone-releasing hormone. The natural hormone is a 44-residue peptide, while the analog is built on a shorter 29-residue fragment.
The original material included a linker that binds serum albumin. A later variant removed that linker to reduce the duration of action. Catalogs and papers did not consistently adopt separate names, so both remain widely labeled with the same term.
The amino acid sequence and the presence or absence of the linker group. Mass measured by spectrometry gives an independent check that separates the two forms.
It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.